Form 4: Hims & Hers Health Director Deborah Autor Acquires 6,175 Shares Through RSU Vesting

Deborah M. Autor, a Director at Hims & Hers Health, Inc., has acquired 6,175 shares of Class A Common Stock following the vesting of Restricted Stock Units.

Summary

• Deborah M. Autor, a Director of Hims & Hers Health, Inc. (HIMS), reported the acquisition of 6,175 shares of Class A Common Stock.
• The acquisition occurred on June 12, 2025, through the vesting of Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Class A Common Stock.
• The RSUs were granted with a vesting condition subject to continuous service.
• The vesting date for these RSUs is the earlier of the 2025 annual meeting of stockholders or June 15, 2025.
• Following this transaction, Deborah M. Autor directly beneficially owns 6,175 shares of Class A Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects a director increasing their direct ownership in the company through a pre-scheduled compensation event, indicating continued alignment and commitment.

Positives

• The vesting of Restricted Stock Units and subsequent acquisition of shares by a director indicates continued commitment and alignment with shareholder interests.
• The transaction increases the director's direct beneficial ownership in the company.

Future Outlook

The vesting of Restricted Stock Units is contingent on continuous service, implying the director's ongoing role and commitment to the company through at least the vesting date in 2025.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, common across all publicly traded companies, and does not provide specific industry-wide context or trends for the telehealth or consumer health sector.

Stakeholder Impact

• Shareholders: The increase in a director's direct ownership can be viewed positively as it aligns the director's interests with those of the shareholders.

Key Dates

Keywords

Hims & Hers Health, HIMS, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Stock Acquisition, Beneficial Ownership, Equity Compensation